Home / Market News / $AGEN
fiscal.ai Corporate Catalyst Impact 55/100 ● positive

B. Riley Securities Maintains Agenus at Buy and Raises Price Target

Nov 9, 2026, 10:39 PM UTC · Primary ticker $AGEN

B. Riley Securities has reiterated its 'Buy' rating for Agenus Inc. and increased its price target from $14 to $16. This upward revision suggests a positive outlook from the analyst firm, implying potential upside for Agenus's stock.

B. Riley Securities maintained its 'Buy' rating on Agenus Inc. and raised its price target from $14 to $16, representing a 14.3% increase. This analyst action is a positive signal for Agenus, as it indicates continued confidence in the company's prospects and a higher valuation expectation from a reputable financial institution. The immediate impact for traders is likely a modest positive sentiment, potentially leading to a slight uptick in AGEN's stock price as investors react to the upgraded target. Long-term implications depend on Agenus's ability to meet or exceed the expectations embedded in this new price target, particularly regarding its clinical pipeline and commercialization efforts. A key opportunity for traders is to consider this analyst upgrade as a potential indicator of future stock performance, though it's important to note that analyst ratings are just one factor in investment decisions.

$AGEN positive Price target increase and maintained 'Buy' rating
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.